Retatrutide (LY3437943)
A powerful triple-action peptide being studied for its effects on appetite, blood sugar, and body weight in lab research.
What Researchers Study
Retatrutide is a lab-made peptide that works on three different "switches" in the body at the same time (GLP-1, GIP, and glucagon receptors). Researchers are interested in how it affects hunger signals, how the body handles sugar and fat, and overall energy use. It is one of the newest and most talked-about compounds in metabolic research right now.
Primary Research Applications
- Studying how multiple hormone pathways work together
- Lab tests on blood sugar control and insulin release
- Looking at fat cells and liver cells in dishes
- Comparing it to older single- or double-action peptides
Benefits Researchers Are Exploring (in simple terms)
- May strongly reduce feelings of hunger in research models by acting on brain appetite centers.
- Early studies suggest it can improve how the body processes sugar and lower blood sugar markers.
- Researchers have seen notable reductions in body weight and fat mass in longer lab and trial settings.
- It appears to increase energy expenditure (the body burns more calories) beyond just reducing food intake.
- Because it hits three pathways, it may give stronger or more complete effects than older single-target peptides.
Mechanisms Under Investigation
Triple Switch Activation
It turns on three different receptors at once. This creates a stronger combined signal for controlling appetite and metabolism than peptides that only hit one or two.
Hunger and Fullness
It affects brain chemicals and gut signals that tell the body "I am full" and slows how fast food leaves the stomach in models.
Sugar and Fat Handling
Used in cell studies to see how it helps cells take up sugar better and changes how fat is stored or burned.
Reconstitution Reference (how to mix it for lab use)
| Common vial sizes | 10 mg and 20 mg lyophilized powder |
| Reconstitution | Add 1-2 mL of bacteriostatic water to a 10 mg vial. This gives 5-10 mg per mL. |
| Storage | Keep the dry powder in the freezer (-20 C). Once mixed, keep it in the fridge (2-8 C) and use within 3-4 weeks. |
| Handling | Use clean technique. Keep it away from light. Do not freeze and thaw the mixed liquid over and over. |
Dosing Schedule Options from Research
Example Options Used in Studies
- Week 1 starting dose (conservative initiation): Draw **30 units** on your 100-unit insulin syringe. This equals 1.5 mg when using the standard research mix of a 10 mg vial + 2 mL bacteriostatic water (5 mg/mL concentration).
- Optimal safe maintenance range: Draw **40 units** (2.0 mg) to **50 units** (2.5 mg) on your 100-unit insulin syringe once per week. This is the commonly referenced optimal safe range when using the standard 5 mg/mL concentration (10 mg vial + 2 mL BAC water).
- Upper limit for this context: Do not exceed **60 units** (3.0 mg) on your 100-unit insulin syringe per week in any research schedule. Still using the 5 mg/mL concentration.
- Cell culture / in-vitro research: Much lower concentrations (nanograms to low micrograms per mL) added directly to cell cultures for short-term experiments (hours to several days). Syringe units do not apply to in-vitro work.
100-Unit Insulin Syringe Conversion Chart
Reconstitution used for these calculations: 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL concentration (standard research reconstitution for easy syringe measurement).
Important: We have already done all the math for you. U-100 insulin syringes are marked in "units" (100 units = 1 mL). Just draw the exact number of units listed below for each dose. No calculations required on your end.
| Dose (mg) | Units on 100-unit syringe (pre-calculated) |
|---|---|
| 1.5 mg (Week 1 start) | 30 units (0.30 mL) |
| 2.0 mg (optimal low) | 40 units (0.40 mL) |
| 2.5 mg (optimal) | 50 units (0.50 mL) |
| 3.0 mg (upper limit - do not exceed) | 60 units (0.60 mL) |
These unit amounts assume the exact concentration listed above. Always double-check your own reconstitution volume against the chart.
Safe Research Cycle Guidelines
Example Cycle References from Research Literature
- Example research cycle: Week 1 at 1.5 mg, then 2.0-2.5 mg weekly for a total of 8-12 weeks on. Minimum 4 weeks off before any repeat cycle (research literature reference only).
- Conservative approach: 8 weeks at 2.0-2.5 mg after initial 1.5 mg titration week, followed by at least 4 weeks recovery period.
- Key limit: Never exceed 3.0 mg per week in any schedule. Titrate slowly and follow approved lab/institutional protocols.
Research Notes
Retatrutide is still an experimental research compound. All information here comes from published lab and early human research studies. Labs must check the original scientific papers for the exact concentrations and methods used in their specific type of experiment.
Order Triple Agonist Peptide — Shop Now
99%+ purity, COA included. Ships fast from Kelowna, BC.
Product Details Shop Now